New Findings on Ketogenic Diet: Low-Carb May Increase Small Intestinal Cancer Risk

The ketogenic diet has swept the globe in recent years, with many supporters touting it for everything from weight loss to blood sugar control. But a new study has thrown a bucket of cold water on this trend: a high-fat, low-carb dietary pattern may help some people lose weight while potentially increasing the risk of small intestinal cancer. This finding forms an intriguing contrast with the previous belief that "the ketogenic diet may prevent colon cancer."

How the Ketogenic Diet Works and Its Two Faces

The core logic of the ketogenic diet is extremely low carbohydrate and high fat, forcing the body to switch from burning glucose to burning fatty acids, producing ketone bodies as an alternative energy source. This metabolic switch does indeed lead to weight loss in the short term, and some clinical studies have observed its potential protective effects against certain tumors.

But the same metabolic mechanism may also have side effects. Research suggests that while the ketogenic diet suppresses colon tumors, it may have different effects on small intestinal tissue. This "organ-specific" difference is precisely the complexity that is easily overlooked in nutritional intervention research.

Ketone bodies are metabolites produced by the liver when glycogen reserves are depleted, converting acetyl-CoA from fatty acid β-oxidation into acetoacetate, β-hydroxybutyrate, and acetone. Among these, β-hydroxybutyrate is not only an alternative fuel but also acts as a signaling molecule to inhibit histone deacetylases, affecting gene expression and inflammatory pathways. This explains why the effects of the ketogenic diet go far beyond simple energy supply substitution—it actually reshapes the metabolic and epigenetic state of cells. Different tissues vary greatly in their ability to take up and utilize ketone bodies. The liver itself lacks enzymes to break down ketone bodies, while the proliferation and apoptosis responses of small intestinal epithelium and colon epithelium under ketone body exposure may be completely different—this is one of the molecular bases of the "organ-specific" effects.

Organ specificity refers to the biological responses triggered by the same systemic intervention in different tissues that may be opposite in direction or vastly different in intensity. Taking the ketogenic diet as an example, its systemic metabolic changes include decreased insulin-like growth factor-1, inhibition of the mTOR pathway, and changes in oxidative stress levels, but these signals may not act consistently in the colonic mucosa and small intestinal villus epithelium. The small intestine is responsible for the main nutrient absorption function, with extremely rapid epithelial turnover, and is more sensitive to lipid load and bile acid stimulation; the colon relies more on short-chain fatty acids produced by microbial fermentation of dietary fiber. Therefore, research conclusions from one organ cannot be simply extrapolated to the entire digestive tract.

What the Small Intestinal Cancer Risk Signal Means

Small intestinal cancer itself is a relatively rare gastrointestinal tumor, with an incidence far lower than colon cancer. But the risk signal raised by the new study is not unfounded—high-fat diets alter bile acid metabolism and affect gut microbiota structure, and these changes may produce pro-inflammatory or pro-proliferative effects in the small intestinal environment.

It should be emphasized that such studies are usually based on animal models or observations of specific populations and cannot be directly interpreted as "eating a ketogenic diet will cause small intestinal cancer." It is more of a reminder: long-term extreme dietary interventions require more cautious monitoring, especially for people with a family history of intestinal diseases.

Bile acid metabolism and its relationship with intestinal tumors is key to understanding this risk signal. High-fat diets stimulate gallbladder contraction and increase bile secretion. Primary bile acids entering the intestine are converted by microbiota into secondary bile acids (such as deoxycholic acid and lithocholic acid). These secondary bile acids are hydrophobic, can embed in cell membranes, induce mitochondrial dysfunction and DNA damage, and activate nuclear receptor pathways such as the farnesoid X receptor to promote epithelial proliferation. In the small intestine, bile acid concentrations are already high, and reabsorption mainly occurs in the terminal ileum, resulting in longer local exposure time—this provides a physiological basis for the "high-fat diet—bile acids—proliferation promotion" chain.

Changes in gut microbiota structure cannot be ignored either. Because the ketogenic diet drastically reduces fermentable carbohydrates, it reduces the substrate supply for beneficial bacteria such as Bifidobacterium and Lactobacillus, while potentially enriching bile-salt-tolerant pro-inflammatory bacterial genera. Microbial dysbiosis can weaken intestinal barrier tight junctions and increase endotoxin entry into the blood, creating a low-grade chronic inflammatory environment. It should be noted that there is still a large gap between the effect strength observed in animal models and the actual risk in humans, and individual baseline microbiota differences may significantly alter the direction of outcomes.

Carbohydrates Should Not Be Simply Demonized

The original title "A reason to eat carbs" reveals another layer of meaning in the study—carbohydrates are not the public enemy of health. Complex carbohydrates in whole grains, legumes, and vegetables provide dietary fiber and short-chain fatty acid substrates for the intestine, with clear benefits for maintaining intestinal barrier function.

A dietary strategy that completely eliminates carbohydrates may show short-term results in weight loss metrics, but at the expense of long-term balance of the gut microbiome. For those seeking weight management, a more pragmatic path is to optimize carbohydrate quality rather than eliminate them wholesale.

Short-chain fatty acids (mainly acetic acid, propionic acid, and butyric acid) are products of dietary fiber fermentation by colonic microbiota. Butyric acid, in particular, is the preferred energy source for colonic epithelial cells, can promote tight junction protein expression, enhance mucus layer secretion, and inhibit histone deacetylases to exert anti-inflammatory and pro-apoptotic effects. Resistant starch and soluble fiber in whole grains, legumes, and vegetables are the main substrates for short-chain fatty acids. An extremely low-carb diet cuts off this supply chain, potentially reducing intestinal butyrate concentrations in the short term and weakening barrier function. This does not mean more carbs are better—refined sugars and polished rice and flour lack fiber and are equally detrimental to microbial diversity. The key lies in the "quality" of carbohydrates rather than their "presence or absence," and this distinction is central to rationally evaluating the ketogenic diet.

How to Rationally View This Study

First, distinguish between "risk signals" and "causal conclusions." A single study is insufficient to overturn the clinical value of the ketogenic diet in specific indications (such as refractory epilepsy). Second, pay attention to individual differences. Metabolic responses vary from person to person, and gut microbiota composition and genetic background will affect the actual effects of dietary interventions. Third, long-term follow-up data are still scarce, and any extreme dietary regimen should be conducted under professional guidance with regular assessment.

The most memorable point of this study may be: the relationship between diet and cancer is never black and white—reducing one risk may raise another. Balance, diversity, and sustainability remain the simplest and most reliable consensus in nutrition.

One-line Summary

New research suggests the ketogenic diet may increase small intestinal cancer risk, contrasting with conclusions about colon cancer prevention.

Paragraph Summary

The article centers on a new study indicating that a high-fat, low-carb ketogenic diet may help with weight loss while potentially increasing the risk of small intestinal cancer, forming an intriguing contrast with the previous belief that the ketogenic diet may prevent colon cancer. The article explains the metabolic logic by which the ketogenic diet forces the body to burn fatty acids and produce ketone bodies, and emphasizes that the same metabolic changes may have vastly different effects in different organs. High-fat diets alter bile acid metabolism and gut microbiota structure, potentially triggering pro-inflammatory or pro-proliferative effects in the small intestinal environment. The article also reminds readers that this is only a risk signal, not a causal conclusion; small intestinal cancer itself is rare, and a single study is insufficient to negate the value of the ketogenic diet in specific indications such as refractory epilepsy. The article concludes that carbohydrates are not the public enemy of health, complex carbohydrates have clear benefits for maintaining intestinal barrier and microbiome balance, and a balanced and diverse diet remains the most reliable consensus in nutrition.